How can an industry averse to change finally be disrupted? Nashville businessmen Chaitanya Hiremath and Richard Flores say they know the answer.

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Guggenheim’s Jason Cassorla gave Cigna’s outlook a caffeine jolt, raising the target price to $388 while maintaining a “Buy” ...

Each of the six major national insurers turned a profit in the first quarter of 2025, though financial pressures related to ...

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to Hold in a note ...